NDC 0132-0325 Boudreauxs Rash Kicking Kit

Zinc Oxide

NDC Product Code 0132-0325

NDC 0132-0325-01

Package Description: 1 KIT in 1 CARTON * 1 TUBE in 1 CARTON > 57 g in 1 TUBE * 1 TUBE in 1 CARTON > 57 g in 1 TUBE

NDC Product Information

Boudreauxs Rash Kicking Kit with NDC 0132-0325 is a a human over the counter drug product labeled by C.b. Fleet Company, Inc.. The generic name of Boudreauxs Rash Kicking Kit is zinc oxide. The product's dosage form is kit and is administered via topical form.

Labeler Name: C.b. Fleet Company, Inc.

Dosage Form: Kit - A packaged collection of related material.

Product Type: Human Otc Drug What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.

Inactive Ingredient(s)

About the Inactive Ingredient(s)
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product.

  • BALSAM PERU (UNII: 8P5F881OCY)
  • CASTOR OIL (UNII: D5340Y2I9G)
  • MINERAL OIL (UNII: T5L8T28FGP)
  • PARAFFIN (UNII: I9O0E3H2ZE)
  • PETROLATUM (UNII: 4T6H12BN9U)
  • BALSAM PERU (UNII: 8P5F881OCY)
  • CASTOR OIL (UNII: D5340Y2I9G)
  • MINERAL OIL (UNII: T5L8T28FGP)
  • PARAFFIN (UNII: I9O0E3H2ZE)
  • PETROLATUM (UNII: 4T6H12BN9U)

Administration Route(s)

What are the Administration Route(s)?
The translation of the route code submitted by the firm, indicating route of administration.

  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Product Labeler Information

What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.

Labeler Name: C.b. Fleet Company, Inc.
Labeler Code: 0132
FDA Application Number: part347 What is the FDA Application Number?
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.

Marketing Category: OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph. What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Start Marketing Date: 05-25-2018 What is the Start Marketing Date?
This is the date that the labeler indicates was the start of its marketing of the drug product.

Listing Expiration Date: 12-31-2021 What is the Listing Expiration Date?
This is the date when the listing record will expire if not updated or certified by the product labeler.

Exclude Flag: N What is the NDC Exclude Flag?
This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA’s requests for correction to deficient or non-compliant submissions. Values = ‘Y’ or ‘N’.

* Please review the disclaimer below.

Boudreauxs Rash Kicking Kit Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Product Labeling Index

Active Ingredient

Zinc oxide, 16%

Zinc oxide, 40%

Purpose

Skin protectant

Skin protectant

Uses

  • Helps treat and prevent diaper rashProtects chafed skin due to diaper rash and helps seal out wetness

  • Helps treat and prevent diaper rashProtects chafed skin due to diaper rash and helps seal out wetness

Warnings

For external use only

For external use only

When Using This Product

Avoid contact with the eyes

Avoid contact with the eyes

Stop Use And Ask A Doctor If

Condition worsens or does not improve after 7 days

Condition worsens or does not improve after 7 days

Keep Out Of The Reach Of Children

To prevent accidental ingestionIf swallowed, seek medical help or call Poison Control Center (1-800-222-1222) immediately

To prevent accidental ingestionIf swallowed, seek medical help or call Poison Control Center (1-800-222-1222) immediately

Directions

  • Change wet and soiled diaper immediatelyCleanse the diaper area and allow to dryApply ointment liberally and as often as necessary with each diaper change and especially when exposed to wet diapers for a prolonged period of time, such as bedtime

  • Change wet and soiled diaper immediatelyCleanse the diaper area and allow to dryApply ointment liberally and as often as necessary with each diaper change and especially when exposed to wet diapers for a prolonged period of time, such as bedtime

Other Information

  • Store at 15°C to 25°C (59°F to 77°F)Remove foil seal from the tube’s tipUse with infants, children and adultsWill stain clothing and fabric

  • Store at 15°C to 25°C (59°F to 77°F)Remove foil seal from the tube’s tipUse with infants, children and adultsWill stain clothing and fabric

Inactive Ingredients

Myroxylon pereiraie (balsam peru) resin, mineral oil, paraffin, petrolatum, ricinus communis (castor) seed oil

Myroxylon pereiraie (balsam peru) resin, mineral oil, paraffin, petrolatum, ricinus communis (castor) seed oil

* Please review the disclaimer below.